PMID- 19141606 OWN - NLM STAT- MEDLINE DCOM- 20090518 LR - 20220331 IS - 1479-683X (Electronic) IS - 0804-4643 (Linking) VI - 160 IP - 5 DP - 2009 May TI - Studies of insulin resistance in patients with clinical and subclinical hypothyroidism. PG - 785-90 LID - 10.1530/EJE-08-0797 [doi] AB - OBJECTIVE: Although clinical hypothyroidism (HO) is associated with insulin resistance, there is no information on insulin action in subclinical hypothyroidism (SHO). DESIGN AND METHODS: To investigate this, we assessed the sensitivity of glucose metabolism to insulin both in vivo (by an oral glucose tolerance test) and in vitro (by measuring insulin-stimulated rates of glucose transport in isolated monocytes with flow cytometry) in 21 euthyroid subjects (EU), 12 patients with HO, and 13 patients with SHO. RESULTS: All three groups had comparable plasma glucose levels, with the HO and SHO having higher plasma insulin than the EU (P<0.05). Homeostasis model assessment index was increased in HO (1.97+/-0.22) and SHO (1.99+/-0.13) versus EU (1.27+/-0.16, P<0.05), while Matsuda index was decreased in HO (3.89+/-0.36) and SHO (4.26+/-0.48) versus EU (7.76+/-0.87, P<0.001), suggesting insulin resistance in both fasting and post-glucose state. At 100 microU/ml insulin: i) GLUT4 levels on the monocyte plasma membrane were decreased in both HO (215+/-19 mean fluorescence intensity, MFI) and SHO (218+/-24 MFI) versus EU (270+/-25 MFI, P=0.03 and 0.04 respectively), and ii) glucose transport rates in monocytes from HO (481+/-30 MFI) and SHO (462+/-19 MFI) were decreased versus EU (571+/-15 MFI, P=0.04 and 0.004 respectively). CONCLUSIONS: In patients with HO and SHO: i) insulin resistance was comparable; ii) insulin-stimulated rates of glucose transport in isolated monocytes were decreased due to impaired translocation of GLUT4 glucose transporters on the plasma membrane; iii) these findings could justify the increased risk for insulin resistance-associated disorders, such as cardiovascular disease, observed in patients with HO or SHO. FAU - Maratou, Eirini AU - Maratou E AD - Hellenic National Center for Research, Prevention and Treatment of Diabetes Mellitus and its Complications (HNDC), GR-10675 Athens, Greece. FAU - Hadjidakis, Dimitrios J AU - Hadjidakis DJ FAU - Kollias, Anastasios AU - Kollias A FAU - Tsegka, Katerina AU - Tsegka K FAU - Peppa, Melpomeni AU - Peppa M FAU - Alevizaki, Maria AU - Alevizaki M FAU - Mitrou, P AU - Mitrou P FAU - Lambadiari, V AU - Lambadiari V FAU - Boutati, Eleni AU - Boutati E FAU - Nikzas, Daniel AU - Nikzas D FAU - Tountas, Nikolaos AU - Tountas N FAU - Economopoulos, Theofanis AU - Economopoulos T FAU - Raptis, Sotirios A AU - Raptis SA FAU - Dimitriadis, George AU - Dimitriadis G LA - eng PT - Comparative Study PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20090113 PL - England TA - Eur J Endocrinol JT - European journal of endocrinology JID - 9423848 RN - 0 (Blood Glucose) RN - 0 (Glucose Transporter Type 3) RN - 0 (Glucose Transporter Type 4) RN - 0 (Insulin) RN - 0 (SLC2A3 protein, human) RN - 0 (SLC2A4 protein, human) SB - IM MH - Adult MH - Blood Glucose/metabolism MH - Cell Membrane/metabolism MH - Cells, Cultured MH - Fasting/blood MH - Glucose Tolerance Test MH - Glucose Transporter Type 3/metabolism MH - Glucose Transporter Type 4/metabolism MH - Humans MH - Hypothyroidism/blood/*metabolism/pathology MH - Insulin/blood/metabolism MH - Insulin Resistance/*physiology MH - Middle Aged MH - Monocytes/metabolism/pathology MH - Thyroid Function Tests EDAT- 2009/01/15 09:00 MHDA- 2009/05/19 09:00 CRDT- 2009/01/15 09:00 PHST- 2009/01/15 09:00 [entrez] PHST- 2009/01/15 09:00 [pubmed] PHST- 2009/05/19 09:00 [medline] AID - EJE-08-0797 [pii] AID - 10.1530/EJE-08-0797 [doi] PST - ppublish SO - Eur J Endocrinol. 2009 May;160(5):785-90. doi: 10.1530/EJE-08-0797. Epub 2009 Jan 13.